First Time Loading...
W

Wockhardt Ltd
NSE:WOCKPHARMA

Watchlist Manager
Wockhardt Ltd
NSE:WOCKPHARMA
Watchlist
Price: 565.95 INR 1.13%
Updated: May 29, 2024

Intrinsic Value

Wockhardt Ltd. engages in the pharmaceutical business. [ Read More ]

The intrinsic value of one WOCKPHARMA stock under the Base Case scenario is 206.3 INR. Compared to the current market price of 565.95 INR, Wockhardt Ltd is Overvalued by 64%.

Key Points:
WOCKPHARMA Intrinsic Value
Base Case
206.3 INR
Overvaluation 64%
Intrinsic Value
Price
W
Worst Case
Base Case
Best Case

Valuation Backtest
Wockhardt Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling WOCKPHARMA stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Ask me anything about
Wockhardt Ltd

Provide an overview of the primary business activities
of Wockhardt Ltd.

What unique competitive advantages
does Wockhardt Ltd hold over its rivals?

What risks and challenges
does Wockhardt Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Wockhardt Ltd.

Provide P/S
for Wockhardt Ltd.

Provide P/E
for Wockhardt Ltd.

Provide P/OCF
for Wockhardt Ltd.

Provide P/FCFE
for Wockhardt Ltd.

Provide P/B
for Wockhardt Ltd.

Provide EV/S
for Wockhardt Ltd.

Provide EV/GP
for Wockhardt Ltd.

Provide EV/EBITDA
for Wockhardt Ltd.

Provide EV/EBIT
for Wockhardt Ltd.

Provide EV/OCF
for Wockhardt Ltd.

Provide EV/FCFF
for Wockhardt Ltd.

Provide EV/IC
for Wockhardt Ltd.

Show me price targets
for Wockhardt Ltd made by professional analysts.

What are the Revenue projections
for Wockhardt Ltd?

How accurate were the past Revenue estimates
for Wockhardt Ltd?

What are the Net Income projections
for Wockhardt Ltd?

How accurate were the past Net Income estimates
for Wockhardt Ltd?

What are the EPS projections
for Wockhardt Ltd?

How accurate were the past EPS estimates
for Wockhardt Ltd?

What are the EBIT projections
for Wockhardt Ltd?

How accurate were the past EBIT estimates
for Wockhardt Ltd?

Compare the revenue forecasts
for Wockhardt Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Wockhardt Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Wockhardt Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Wockhardt Ltd compared to its peers.

Compare the P/E ratios
of Wockhardt Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Wockhardt Ltd with its peers.

Analyze the financial leverage
of Wockhardt Ltd compared to its main competitors.

Show all profitability ratios
for Wockhardt Ltd.

Provide ROE
for Wockhardt Ltd.

Provide ROA
for Wockhardt Ltd.

Provide ROIC
for Wockhardt Ltd.

Provide ROCE
for Wockhardt Ltd.

Provide Gross Margin
for Wockhardt Ltd.

Provide Operating Margin
for Wockhardt Ltd.

Provide Net Margin
for Wockhardt Ltd.

Provide FCF Margin
for Wockhardt Ltd.

Show all solvency ratios
for Wockhardt Ltd.

Provide D/E Ratio
for Wockhardt Ltd.

Provide D/A Ratio
for Wockhardt Ltd.

Provide Interest Coverage Ratio
for Wockhardt Ltd.

Provide Altman Z-Score Ratio
for Wockhardt Ltd.

Provide Quick Ratio
for Wockhardt Ltd.

Provide Current Ratio
for Wockhardt Ltd.

Provide Cash Ratio
for Wockhardt Ltd.

What is the historical Revenue growth
over the last 5 years for Wockhardt Ltd?

What is the historical Net Income growth
over the last 5 years for Wockhardt Ltd?

What is the current Free Cash Flow
of Wockhardt Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Wockhardt Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Wockhardt Ltd

Current Assets 20.4B
Cash & Short-Term Investments 840m
Receivables 7.5B
Other Current Assets 12.1B
Non-Current Assets 53.8B
Long-Term Investments 620m
PP&E 23.5B
Intangibles 21.9B
Other Non-Current Assets 7.9B
Current Liabilities 26.9B
Accounts Payable 8B
Short-Term Debt 10.4B
Other Current Liabilities 8.5B
Non-Current Liabilities 16.1B
Long-Term Debt 11.7B
Other Non-Current Liabilities 4.4B
Efficiency

Earnings Waterfall
Wockhardt Ltd

Revenue
27.8B INR
Cost of Revenue
-11.8B INR
Gross Profit
16B INR
Operating Expenses
-16.6B INR
Operating Income
-640m INR
Other Expenses
-4.4B INR
Net Income
-5B INR

Free Cash Flow Analysis
Wockhardt Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

WOCKPHARMA Profitability Score
Profitability Due Diligence

Wockhardt Ltd's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive 3-Years Revenue Growth
Positive 1-Year Revenue Growth
ROIC is Increasing
38/100
Profitability
Score

Wockhardt Ltd's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

WOCKPHARMA Solvency Score
Solvency Due Diligence

Wockhardt Ltd's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
31/100
Solvency
Score

Wockhardt Ltd's solvency score is 31/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

WOCKPHARMA Price Targets Summary
Wockhardt Ltd

Wall Street analysts forecast WOCKPHARMA stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for WOCKPHARMA is 450 INR .

Lowest
Price Target
Not Available
Average
Price Target
450 INR
20% Downside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

WOCKPHARMA Price
Wockhardt Ltd

1M 1M
-2%
6M 6M
+74%
1Y 1Y
+234%
3Y 3Y
-13%
5Y 5Y
+44%
10Y 10Y
-1%
Annual Price Range
565.95
52w Low
168.3
52w High
613.75
Price Metrics
Average Annual Return 4.89%
Standard Deviation of Annual Returns 83.16%
Max Drawdown -81%
Shares Statistics
Market Capitalization 80.6B INR
Shares Outstanding 153 400 992
Percentage of Shares Shorted
N/A

WOCKPHARMA Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Wockhardt Ltd

Country

India

Industry

Pharmaceuticals

Market Cap

80.6B INR

Dividend Yield

0%

Description

Wockhardt Ltd. engages in the pharmaceutical business. The company is headquartered in Mumbai, Maharashtra and currently employs 2,962 full-time employees. The firm's businesses include manufacture and marketing of pharmaceutical and bio-pharmaceutical formulations, active pharmaceutical ingredients (APIs) and vaccines. The company manufactures a range of dosage forms, including sterile injectables and lyophilized products. The firm offers products in therapeutic areas of dermatology, cosmeceuticals, oncology, medical nutrition, osteoarthritis, pain management, nephrology, cough therapy and diabetology. The Company’s products across India includes Citawok, Citawok Forte, Citawok Plus, CONSEGNA 30/70 U-200 CART, CONSEGNA R U-200 CART, DARBOTIN PFS, DECDAN, DECDAN B, DECDAN B Injection, DECDAN LITE CREAM, Emrok, Emrok O, Erliso, FOSCHEK-S, Gabawok NT, GLARITUS CART, GLARITUS DISPO, Glimaday, INOGLA, Livatira, GLARITUS CART and VAL 450. The firm has approximately three research centers globally and a chain of six super-specialty hospitals across Maharashtra and Gujarat.

Contact

MAHARASHTRA
Mumbai
Wockhardt Towers, Bandra Kurla Complex, Bandra (East)
+912226534444
http://www.wockhardt.com/

IPO

1994-02-25

Employees

2 962

Officers

Founder & Executive Chairman
Dr. Habil Fakhruddin Khorakiwala
MD & Executive Director
Dr. Murtaza Habil Khorakiwala
Executive Director
Dr. Huzaifa Habil Khorakiwala
Chief Financial Officer
Mr. Deepak R. Madnani
Chief Scientific Officer of New Drug Discovery
Dr. Mahesh V. Patel
Senior Vice President of Legal
Ms. Debolina Partap
Show More
Chief Human Resource Officer
Mr. Neeraj Agarwal
Senior Vice President of Business Development
Mr. Anil V. Kamath AMRSH (Lon.), BCom (Hons), MBIM (Lon.), MIMA
Head of Global Regulatory Affairs
Mr. Zoher T. Sihorwala
President of Supply Chain
Mr. Prakash Gupta
Show Less

See Also

Discover More
What is the Intrinsic Value of one WOCKPHARMA stock?

The intrinsic value of one WOCKPHARMA stock under the Base Case scenario is 206.3 INR.

Is WOCKPHARMA stock undervalued or overvalued?

Compared to the current market price of 565.95 INR, Wockhardt Ltd is Overvalued by 64%.